
DD Stock: Earnings Beat, Valuation and Risks
DuPont reported a quarterly earnings beat and has expanded its high-purity water portfolio, while a new AI collaboration adds a longer-term innovation angle. Shares closed at $153.78 on Friday, November 13, near their 52-week high, but weak ROE, chemical-market headwinds and conflicting analyst targets make the risk and valuation picture mixed.
Executive Summary
Investment Thesis: DuPont's latest reported EPS of $2.09 exceeded the $1.87 estimate, and new electrodeionization products target industrial and semiconductor water applications. A collaboration with Microsoft and NobleAI could support research and development, though its financial impact is not yet known. DD's shares closed at $153.78 on Friday, November 13, near the 52-week high, while low reported ROE, cyclical demand risks and a supplied mean analyst target below the share price argue for a balanced assessment.
Current Price: $153.78, as of Friday, November 13 | Key Metric: 68.35 trailing P/E | Stance: NEUTRAL
U.S. stock markets are closed on Saturday, November 14. The quoted price and daily change refer to the last trading session, Friday, November 13. The report uses the supplied company and analyst data, while noting where a separate finance-data feed reports different figures.
Company Overview
DuPont de Nemours, Inc. is a materials and specialty-products company serving industrial, electronics, water-treatment and other end markets. Its products are used in applications where material performance, process reliability and purity can matter more than commodity price alone.
Key Products & Competitive Position
- Core Business: Specialty materials and technologies for industrial and electronics markets, alongside water purification and treatment solutions.
- Key Products: The recent launch of four high-flow electrodeionization, or EDI, modules expands DuPont's portfolio for high-purity water applications, including microelectronics and industrial processes.
- Competitive Moat: Application expertise, customer qualification requirements and established product portfolios may support customer retention. Those advantages are not guarantees of pricing power or growth, particularly when customers face cyclical demand.
Recent Developments
On November 12, DuPont announced a collaboration with Microsoft and NobleAI to expand access to AI tools, including machine learning, for research and development. The initiative may help researchers evaluate materials and processes, but the company has not provided a quantified earnings contribution. DuPont also introduced high-flow EDI modules on November 9, positioning the product line for water-treatment demand from industrial and semiconductor customers. On November 13, it received Wolters Kluwer's 2026 Legal Innovator Award, a recognition of legal operations rather than a direct indicator of operating performance.
Financial Snapshot
Revenue & Earnings Trends
A separate finance-data feed reports trailing revenue of approximately $7.06 billion, revenue growth of 4.1%, EBITDA of about $1.64 billion and a 23.21% EBITDA margin. It also reports net income to common shareholders of $388 million and a 4.26% profit margin. These figures suggest positive but modest reported revenue growth, with profitability that remains more constrained than the EBITDA margin alone might imply.
The supplied trailing EPS of $2.24 and P/E of 68.35 indicate that the current price is high relative to recent earnings. Another data feed reports trailing EPS of $2.85, illustrating that providers can differ in their earnings period or methodology. The latest supplied quarterly result is clearer: EPS of $2.09 beat the $1.87 estimate, a beat of $0.22, or about 11.8%. A single quarter does not establish a durable earnings trend.
Balance Sheet Highlights
The reported current ratio of 2.36 and quick ratio of 1.58 indicate current assets exceed short-term obligations in the data provided. The separate feed lists $1.65 billion of cash and $3.18 billion of total debt, implying net debt of roughly $1.53 billion. Compared with reported EBITDA of $1.64 billion, that is approximately 0.9 times EBITDA, a moderate snapshot that should be considered alongside future cash generation and capital needs.
ROE of 2.18% is low and warrants attention. It can reflect subdued net profitability, the equity base, or both. Reported free cash flow in the separate feed appears difficult to reconcile with its operating cash flow figure, so it is not used here as evidence of cash-generation strength.
Valuation Analysis
Current Valuation Metrics
Forward P/E, enterprise value and EBITDA are taken from the separate finance-data feed; EV/EBITDA is calculated from its $22.03 billion enterprise value and $1.64 billion EBITDA. P/S is calculated using the supplied market capitalization and that feed's $7.06 billion revenue. No consistent industry averages or five-year valuation series were supplied, so a direct peer or historical premium comparison would be unreliable.
Historical Comparison
The available two-year price history reports an average closing price of $113.79 and a total return of 53.21%. That history puts the current quote well above the average close, but it is not a substitute for a five-year valuation comparison and does not show whether earnings growth has kept pace. The shares are also just 3.6% below the stated 52-week high.
Fair Value Estimate
A rough multiple-based sensitivity illustrates why the valuation depends on earnings assumptions. Dividing $153.78 by the reported 18.81 forward P/E implies forward EPS of about $8.18, which is substantially above the supplied trailing EPS. Applying a hypothetical 17 to 21 times multiple to that implied forward EPS gives a broad range of about $139 to $172 per share. This is not a formal forecast: it depends on the forward earnings figure, which may differ from realized results.
The supplied analyst mean target of $142.20 is about 7.5% below the current price, while its median target of $160 is modestly above it. A separate finance feed reports a higher mean target of $172.47 and a range of $145 to $190. Different analyst samples and update dates can produce divergent aggregates, so neither set should be treated as a precise fair-value measure.
Competitive Landscape
Market Position
Market Share: Not quantified in the supplied data | Ranking: Not established by the available figures
DuPont competes across specialty materials and water-treatment applications rather than one clearly defined market with a single comparable share figure. Its high-purity water products may address expanding needs in semiconductor manufacturing and industrial processing, but the size of the opportunity and DuPont's share of it were not provided.
Key Competitors
Competitive Advantages
- Application Expertise: Specialty materials and purification products can require technical know-how and performance testing that may make customer qualification important.
- Portfolio Breadth: Products serving several industrial and electronics uses can spread exposure across more than one end market, though they do not eliminate cyclicality.
- Innovation Potential: The AI collaboration and new EDI modules are examples of efforts to improve research capabilities and broaden product applications. Commercial results remain to be demonstrated.
Earnings Track Record
Last 4 Quarters: 1 documented beat / 0 documented misses, three other quarter comparisons not supplied
Recent Earnings History
The November 3 report is treated as the Q3 2026 result based on the supplied dates. Only this quarter's actual and consensus EPS were provided, so the record above does not infer outcomes for earlier quarters.
Guidance Trend
No revised full-year guidance or history of guidance changes was included in the supplied information. The next listed earnings report is expected on February 9, 2027, with an EPS estimate of $1.92. Investors can compare that result with the estimate and management's commentary on end-market demand, margins and product adoption when released.
Analyst Sentiment
Consensus Rating:
The consensus label is a third-party analyst classification, not an investment recommendation. The separate finance feed gives a buy recommendation mean of 1.61 across 17 analyst opinions, so the sample and ratings can differ by source.
Price Targets
- Low: $53
- Mean: $142.20 (-7.5% versus $153.78)
- High: $172
The supplied target range is unusually wide, from $53 to $172, underscoring disagreement among analysts. A separate feed lists a $145 low, $172.47 mean, $173 median and $190 high. The latter feed also reports recent target increases: RBC Capital to $173 from $160, Wells Fargo to $170 from $166, UBS to $182 from $172, and Citigroup to $176 from $162, all between November 4 and November 5. These target changes indicate improved analyst expectations, but they do not remove operating or valuation uncertainty.
Recent Analyst Actions
The reported actions were target increases while the firms maintained their existing ratings. The higher targets followed the recent earnings report, although the available data does not establish each firm's reasoning. Because the target datasets conflict, readers may want to track the date, analyst coverage count and methodology behind any consensus figure they use.
Recent News & Catalysts
Key Developments
- AI Research Collaboration: DuPont announced a collaboration with Microsoft and NobleAI on November 12 to broaden access to advanced AI and machine-learning tools for research and development. The potential benefit is longer term, and no quantified savings or revenue contribution has been disclosed.
- High-Flow EDI Modules: The November 9 launch expands DuPont's high-purity water offerings for industrial and microelectronics applications. Semiconductor-related demand is a potential growth driver, but adoption, customer wins and revenue impact remain to be measured.
- Industry Conditions and Recognition: A November 11 industry report described sluggish demand in key end markets and softness in Europe and China. DuPont also received a legal-innovation award on November 13, which is positive recognition but not a direct earnings catalyst.
Upcoming Catalysts
Next Earnings: February 9, 2027, expected | Key Events: Q4 and full-year results, 2027 outlook, evidence of EDI module adoption, and updates on AI-enabled R&D
The next earnings date is forward-looking and was supplied as both the expected report date and earnings date. The date and consensus estimate can change. Broader chemical-sector demand, especially in Europe and China, may also influence results before that report.
Technical Outlook
Current Price: $153.78 as of Friday, November 13 vs 52-Week High: $159.48 (-3.6% from high)
Trend Analysis
The price is in the upper part of its stated 52-week range of $111.15 to $159.48, and the supplied two-year data reports a 53.21% total return. On Friday, November 13, the shares closed down $0.92, or 0.59%, from the prior close of $154.70 after trading between $151.79 and $156. The proximity to the annual high signals strong prior price performance, but the data provided does not include moving averages, relative strength or volume indicators needed for a fuller technical assessment.
Key Levels
- Resistance: Around $156, the supplied Friday session high, then $159.48, the 52-week high.
- Support: Around $151.79 to $152, the Friday session low area, then approximately $145 as a reference from the separate analyst target range, not a confirmed technical floor.
These are reference levels drawn from the supplied price data, not predictive signals. U.S. markets are closed for the weekend, with the next regular session scheduled for Monday, November 16.
Bull vs Bear Case
Bull Case
- Catalyst 1: The latest reported EPS beat could support confidence if subsequent results show that the performance is repeatable.
- Catalyst 2: EDI modules may benefit from rising requirements for high-purity water in semiconductor and industrial operations, while AI tools could improve R&D productivity over time.
- Catalyst 3: Several analysts raised targets in early November, and the separate feed's forward P/E of 18.81 is well below the supplied trailing P/E, reflecting expectations for higher forward earnings.
Bull Target: $172, an illustrative scenario based on the supplied high target, not a forecast
Bear Case
- Risk 1: Sluggish demand in key end markets and softness in Europe and China could restrain sales, utilization and margins.
- Risk 2: ROE of 2.18% and profit margin of 4.26% point to limited reported returns and leave execution dependent on earnings improvement.
- Risk 3: The 68.35 trailing P/E is elevated relative to supplied trailing EPS, and the supplied mean target is below the current price. A shortfall against forward earnings assumptions could pressure valuation.
Bear Target: $130, an illustrative downside sensitivity of about 15.5%, not an analyst consensus or forecast
The scenario figures are analytical reference points rather than expected outcomes. The bull case uses the provided high target; the bear case is an illustrative valuation stress level and is not sourced from a specific analyst target.
Risks to Consider
- Valuation Risk: The supplied trailing P/E is 68.35, and the share price is near its 52-week high. If expected earnings growth does not materialize, a lower earnings multiple could weigh on the shares.
- Competitive Risk: Specialty materials and water-treatment markets include established competitors. New product launches need to translate into customer adoption and defensible returns.
- Macro Risk: Chemical demand can be sensitive to industrial activity, manufacturing cycles, foreign-exchange shifts and regional conditions. The reported softness in Europe and China is a relevant near-term headwind.
- Execution Risk: AI-enabled R&D and new EDI products may take time to deliver measurable commercial value. Product development, customer qualification and scaling all carry uncertainty.
Other considerations include the low reported ROE, inconsistent data-provider EPS and target figures, and limited information on full-year guidance. These make it important to check the reporting basis and update date when comparing metrics.
Bottom Line
Investment Verdict: NEUTRAL
DuPont combines a recent earnings beat, analyst target increases and product initiatives in high-purity water with meaningful uncertainty about demand, profitability and valuation. The shares closed near the 52-week high, while the supplied mean analyst target implies a value below that close; conflicting target feeds and a large gap between trailing and forward earnings measures reinforce the need to treat headline metrics cautiously. This report presents market analysis for informational purposes only and is not investment advice.
Action Items for Investors
- Long-term investors: Track whether new water-treatment products gain customers and whether AI-assisted R&D produces measurable productivity or product outcomes. These are monitoring points, not a security recommendation.
- Short-term traders: Note the Friday close, session range and 52-week high, while recognizing that the supplied data lacks volume and moving-average signals. The market is closed for the weekend and next opens Monday, November 16.
- Risk management: Consider how sensitive an investment thesis would be to weaker industrial demand, a miss against forward earnings expectations or a change in analyst estimates. Verify valuation inputs across sources before relying on a single consensus figure.
What to Watch This Week
- Any company updates on customer response to the new high-flow EDI modules and semiconductor-related demand.
- Developments in industrial demand, particularly commentary about Europe and China.
- Trading and price behavior when U.S. markets reopen Monday, November 16, while keeping the Friday, November 13 close as the latest completed session.
Sources
Share this report
Share this article
Spread the word on social media
Think DD will outperform? Prove it.
Free practice contests — earn Alpha CoinsExplore More Content
Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.
Spotted something wrong? Report an error.